ArticleNeoplasia (New York, N.Y.)2026

Low dose radiotherapy-induced tumor-preferential antigens enhance antibody-drug conjugate efficacy in solid tumors.

Yun Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.